Page 1 | Search Results | Blood Neoplasia | American Society of Hematology

1-20 of 186

Sort by

Sort Order Select

Journal Articles

The LMO2-LDB1-TAL1 complex regulates transcription networks in Acute Myeloid Leukemia

Blood Neoplasia 100186.

https://doi.org/10.1016/j.bneo.2025.100186

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of Age on Outcomes after CD19 CAR-T Cell Therapy for Large B-Cell Lymphomas

Blood Neoplasia 100187.

https://doi.org/10.1016/j.bneo.2025.100187

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes of transplant-eligible and transplant-ineligible patients with mantle cell lymphoma in Ontario

Adam Suleman, Zharmaine Ante, Ning Liu, Michael Crump, Kelvin KW Chan, Matthew C. Cheung, Anca Prica

Blood Neoplasia 100184.

https://doi.org/10.1016/j.bneo.2025.100184

Published: 2025

Includes: Supplemental data

Journal Articles

SKIDA1 sustains MLL::ENL-expressing hematopoietic progenitors during neonatal stages and promotes B-lineage priming

Jonny Mendoza-Castrejon, Wei Yang, Elisabeth Denby, Rohini Muthukumar, Emily B. Casey, Riddhi M. Patel, Sarah K. Tasian, Jeffrey A. Magee

Blood Neoplasia 100185.

https://doi.org/10.1016/j.bneo.2025.100185

Published: 2025

Includes: Supplemental data

Journal Articles

Mezigdomide Combined with Bortezomib Disrupts Cell Cycle and Elicits Superior Anti-Tumor Effects in Multiple Myeloma

Blood Neoplasia 100179.

https://doi.org/10.1016/j.bneo.2025.100179

Published: 2025

Includes: Supplemental data

Journal Articles

Ratios of CD8 T Lymphocytes to M-MDSCs (CD8MMR) Predict Prognosis in Untreated DLBCL Patients

Hao-Yuan Wang, Fu-Chen Yang, Ching-Fen Yang, Chun-Kuang Tsai, Po-Chun Liu, Po-Shen Ko, Yao-Chung Liu, Jyh-Pyng Gau, Jin-Hwang Liu, Po-Min Chen, Nien-Jung Chen

Blood Neoplasia 100180.

https://doi.org/10.1016/j.bneo.2025.100180

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of European LeukemiaNet (ELN) guided post-remission therapy on outcome of patients with AML from 2010-2022

Andrew F. Berdel, Julian Ronnacker, Daniela V. Wenge, Lina J. Kolloch, Philipp Berning, Linus Angenendt, Tobias J. Brix, Annette Westermann, Klaus Wethmar, Torsten Kessler, Andrea Kerkhoff, Rolf M. Mesters, Christian Reicherts, Jan-Henrik Mikesch, Wolfgang E. Berdel, Georg Lenz, Christoph Schliemann, Matthias Stelljes

Blood Neoplasia 100181.

https://doi.org/10.1016/j.bneo.2025.100181

Published: 2025

Includes: Supplemental data

Journal Articles

Single-cell proteogenomic analysis of clonal evolution in PDX models of AML treated with IDH inhibitors

Blood Neoplasia 100182.

https://doi.org/10.1016/j.bneo.2025.100182

Published: 2025

Includes: Supplemental data

Journal Articles

Adapted physical activity for hematology inpatients: focus on lean mass gain

Axel Sudria, Michael Loschi, Andrea Pinto, Laura Crousse, Sami Benachour, Rinzine Sammut, Frederic Chorin, Nicolas Mounier, Thomas Cluzeau

Blood Neoplasia 100183.

https://doi.org/10.1016/j.bneo.2025.100183

Published: 2025

Includes: Supplemental data

Journal Articles

Predicting secondary myeloid neoplasms in acquired aplastic anemia using machine learning models

Ahmet Celal Toprak, Mutlu Mete, Julia J. Shi, Daria V. Babushok, Carmelo Gurnari, Jaroslaw P. Maciejewski, Zoe Bass, Zehra Tombul, Carlos. I. A. Santos, Munevver N. Duran, Hussein Awada, Ibrahim Ibrahim, Alper Olcal, Yusuf Ozcan, Leslie Guerrero, Julio Alvarenga Thiebaud, Taha Bat

Blood Neoplasia (2025) 2 (4): 100163.

https://doi.org/10.1016/j.bneo.2025.100163

Published: 2025

Includes: Supplemental data

Journal Articles

Real-world analysis of polycythemia vera treatment reveals nonadherence to NCCN guidelines in a large proportion of patients

Ghaith Abu-Zeinah, Anthony M. Hunter, Joseph J. Shatzel, Abdulraheem Yacoub, Albert Qin, Hung-Lun Chien, Ruben A. Mesa

Blood Neoplasia (2025) 2 (4): 100167.

https://doi.org/10.1016/j.bneo.2025.100167

Published: 2025

Includes: Supplemental data

Journal Articles

T-cell immune profile changes predict durable response to nivolumab-rituximab in treatment-naïve FL

Rachel M. Koldej, Allison Barraclough, Huw Morgan, Sze Ting Lee, Nicholas Holzwart, Minu Koshy, Charmaine Smith, Geoffrey Chong, Michael Gilbertson, Colm Keane, Denise Lee, Leonid Churilov, David S. Ritchie, Eliza A. Hawkes

Blood Neoplasia (2025) 2 (4): 100168.

https://doi.org/10.1016/j.bneo.2025.100168

Published: 2025

Includes: Supplemental data

Journal Articles

Luspatercept treatment affects immune-regulatory subsets in patients with MDS with ring sideroblasts

Stefania Leone, Francesco Grimaldi, Mara Memoli, Giulia Scalia, Annamaria Vincenzi, Maria Di Perna, Giuseppe Cerciello, Antonio Vassallo, Fabrizio Pane, Alessandra Picardi, Giuseppe Terrazzano, Giuseppina Ruggiero, Flavia Carriero, Valentina Rubino

Blood Neoplasia (2025) 2 (4): 100170.

https://doi.org/10.1016/j.bneo.2025.100170

Published: 2025

Includes: Supplemental data

Journal Articles

Hoff FW, Yocum AO, Borate UM, et al. Beat AML genetic risk stratification model in a cohort of older VEN/HMA-treated patients with AML. Blood Neoplasia. 2025;2(3):100125.

Blood Neoplasia (2025) 2 (4): 100169.

https://doi.org/10.1016/j.bneo.2025.100169

Published: 2025

Journal Articles

Application of the International Working Group MDS molecular taxonomy classes to a single institution cohort

Rohiverth Guarecuco, Lisa Yuen, Maxwell Roth, Brandon J. Aubrey, Andrew M. Brunner, Robert P. Hasserjian

Blood Neoplasia (2025) 2 (4): 100162.

https://doi.org/10.1016/j.bneo.2025.100162

Published: 2025

Includes: Supplemental data

Journal Articles

Second malignancies among older patients with classical myeloproliferative neoplasms treated with ruxolitinib

Rong Wang, Jessica M. Stempel, Rory M. Shallis, Scott F. Huntington, Amer M. Zeidan, Natalia Neparidze, Mengyang Di, Jan Philipp Bewersdorf, Lourdes Mendez, Xiaomei Ma, Nikolai A. Podoltsev

Blood Neoplasia (2025) 2 (4): 100159.

https://doi.org/10.1016/j.bneo.2025.100159

Published: 2025

Journal Articles

EXTENDED LONG TERM FOLLOW UP AND THE SURVIVAL OF STOP IMATINIB STUDY (STIM1)

François-Xavier Mahon, Stéphanie Dulucq, Delphine Réa, Franck Nicolini, Françoise Rigal-Huguet, Katerina Machova Polakova, Viviane Dubruille, Marie-Pierre Noel, Jean-Christophe Ianotto, Bruno Villemagne, Émilie Cayssials, Sophie Park, Philippe Rousselot, Gabriel Etienne

Blood Neoplasia 100177.

https://doi.org/10.1016/j.bneo.2025.100177

Published: 2025

Includes: Supplemental data

Journal Articles

Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomas

Julio C. Chavez, Ellen Napier, Attilio Bondanza, Andrew Lewandowski, Jennifer Mataraza, David Quinn, Paul Kwon, Frederick L. Locke, Boris Engels, Rakesh Awasthi, Petrina Georgala, Malgorzata Leyk, David Hynds, Michele Moschetta, Stephen J. Schuster

Blood Neoplasia 100176.

https://doi.org/10.1016/j.bneo.2025.100176

Published: 2025

Includes: Supplemental data

Journal Articles

Dual FLT3/PIM inhibitor dapolsertib (MEN1703) in acute myeloid leukemia: results from the phase 1/2 DIAMOND-01 trial

Blood Neoplasia 100178.

https://doi.org/10.1016/j.bneo.2025.100178

Published: 2025

Includes: Supplemental data

Journal Articles

PHASE Ib PILOT STUDY OF ITACITINIB WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA

Tapan M. Kadia, Akhil Jain, Caitlin R. Rausch, Alex Bataller, Farhad Ravandi, Elias Jabbour, Wei Qiao, Gautam Borthakur, Nicholas Short, Guillermo Montalban-Bravo, Andres E. Quesada, Jan Burger, Alessandra Ferrajoli, William Wierda, Chitra Hosing, Hagop Kantarjian

Blood Neoplasia 100175.

https://doi.org/10.1016/j.bneo.2025.100175

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Date

Availability

The LMO2-LDB1-TAL1 complex regulates transcription networks in Acute Myeloid Leukemia

Impact of Age on Outcomes after CD19 CAR-T Cell Therapy for Large B-Cell Lymphomas

Outcomes of transplant-eligible and transplant-ineligible patients with mantle cell lymphoma in Ontario

SKIDA1 sustains MLL::ENL-expressing hematopoietic progenitors during neonatal stages and promotes B-lineage priming

Mezigdomide Combined with Bortezomib Disrupts Cell Cycle and Elicits Superior Anti-Tumor Effects in Multiple Myeloma

Ratios of CD8 T Lymphocytes to M-MDSCs (CD8MMR) Predict Prognosis in Untreated DLBCL Patients

Impact of European LeukemiaNet (ELN) guided post-remission therapy on outcome of patients with AML from 2010-2022

Single-cell proteogenomic analysis of clonal evolution in PDX models of AML treated with IDH inhibitors

Adapted physical activity for hematology inpatients: focus on lean mass gain

Predicting secondary myeloid neoplasms in acquired aplastic anemia using machine learning models

Real-world analysis of polycythemia vera treatment reveals nonadherence to NCCN guidelines in a large proportion of patients

T-cell immune profile changes predict durable response to nivolumab-rituximab in treatment-naïve FL

Luspatercept treatment affects immune-regulatory subsets in patients with MDS with ring sideroblasts

Hoff FW, Yocum AO, Borate UM, et al. Beat AML genetic risk stratification model in a cohort of older VEN/HMA-treated patients with AML. Blood Neoplasia. 2025;2(3):100125.

Application of the International Working Group MDS molecular taxonomy classes to a single institution cohort

Second malignancies among older patients with classical myeloproliferative neoplasms treated with ruxolitinib

EXTENDED LONG TERM FOLLOW UP AND THE SURVIVAL OF STOP IMATINIB STUDY (STIM1)

Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomas

Dual FLT3/PIM inhibitor dapolsertib (MEN1703) in acute myeloid leukemia: results from the phase 1/2 DIAMOND-01 trial

PHASE Ib PILOT STUDY OF ITACITINIB WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only